These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34175563)

  • 1. A bilirubin-derived nanomedicine attenuates the pathological cascade of pulmonary fibrosis.
    Keum H; Kim D; Kim J; Kim TW; Whang CH; Jung W; Jon S
    Biomaterials; 2021 Aug; 275():120986. PubMed ID: 34175563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilirubin nanoparticles ameliorate allergic lung inflammation in a mouse model of asthma.
    Kim DE; Lee Y; Kim M; Lee S; Jon S; Lee SH
    Biomaterials; 2017 Sep; 140():37-44. PubMed ID: 28624706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilirubin Nanoparticles as a Nanomedicine for Anti-inflammation Therapy.
    Lee Y; Kim H; Kang S; Lee J; Park J; Jon S
    Angew Chem Int Ed Engl; 2016 Jun; 55(26):7460-3. PubMed ID: 27144463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilirubin nanomedicine alleviates psoriatic skin inflammation by reducing oxidative stress and suppressing pathogenic signaling.
    Keum H; Kim TW; Kim Y; Seo C; Son Y; Kim J; Kim D; Jung W; Whang CH; Jon S
    J Control Release; 2020 Sep; 325():359-369. PubMed ID: 32681946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilirubin nanomedicine ameliorates the progression of experimental autoimmune encephalomyelitis by modulating dendritic cells.
    Kim TW; Kim Y; Jung W; Kim DE; Keum H; Son Y; Jon S
    J Control Release; 2021 Mar; 331():74-84. PubMed ID: 33450316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled Lipid Nanoparticles Alleviate Established Pulmonary Fibrosis.
    Li D; Zhao A; Zhu J; Wang C; Shen J; Zheng Z; Pan F; Liu Z; Chen Q; Yang Y
    Small; 2023 Jul; 19(30):e2300545. PubMed ID: 37058092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilirubin Nanoparticles Protect Against Cardiac Ischemia/Reperfusion Injury in Mice.
    Ai W; Bae S; Ke Q; Su S; Li R; Chen Y; Yoo D; Lee E; Jon S; Kang PM
    J Am Heart Assoc; 2021 Oct; 10(20):e021212. PubMed ID: 34622671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potency of compound RMY-205 for pulmonary fibrosis induced by SARS-CoV-2 nucleocapsid protein.
    Zhang ZY; Ju CY; Wu LZ; Yan H; Hong WB; Chen HZ; Yang PB; Wang BR; Gou T; Chen XY; Jiang ZH; Wang WJ; Lin T; Li FN; Wu Q
    Cell Chem Biol; 2023 Mar; 30(3):261-277.e8. PubMed ID: 36889311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD147 contributes to SARS-CoV-2-induced pulmonary fibrosis.
    Wu J; Chen L; Qin C; Huo F; Liang X; Yang X; Zhang K; Lin P; Liu J; Feng Z; Zhou J; Pei Z; Wang Y; Sun XX; Wang K; Geng J; Zheng Z; Fu X; Liu M; Wang Q; Zhang Z; Bian H; Zhu P; Chen ZN
    Signal Transduct Target Ther; 2022 Nov; 7(1):382. PubMed ID: 36424379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary Fibrosis Caused by Severe COVID-19 Infection: Discharge May Not Be The End of Treatment.
    Rumende CM
    Acta Med Indones; 2021 Apr; 53(2):141-142. PubMed ID: 34251340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus infection induced pulmonary fibrosis.
    Huang WJ; Tang XX
    J Transl Med; 2021 Dec; 19(1):496. PubMed ID: 34876129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Black Pigment Gallstone Inspired Platinum-Chelated Bilirubin Nanoparticles for Combined Photoacoustic Imaging and Photothermal Therapy of Cancers.
    Lee DY; Kim JY; Lee Y; Lee S; Miao W; Kim HS; Min JJ; Jon S
    Angew Chem Int Ed Engl; 2017 Oct; 56(44):13684-13688. PubMed ID: 28869355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRD4 targeting nanotherapy prevents lipopolysaccharide induced acute respiratory distress syndrome.
    Pooladanda V; Thatikonda S; Muvvala SP; Devabattula G; Godugu C
    Int J Pharm; 2021 May; 601():120536. PubMed ID: 33781885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multistimuli-Responsive Bilirubin Nanoparticles for Anticancer Therapy.
    Lee Y; Lee S; Lee DY; Yu B; Miao W; Jon S
    Angew Chem Int Ed Engl; 2016 Aug; 55(36):10676-80. PubMed ID: 27485478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilirubin ameliorates bleomycin-induced pulmonary fibrosis in rats.
    Wang HD; Yamaya M; Okinaga S; Jia YX; Kamanaka M; Takahashi H; Guo LY; Ohrui T; Sasaki H
    Am J Respir Crit Care Med; 2002 Feb; 165(3):406-11. PubMed ID: 11818329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive Pulmonary Fibrosis After Non-Critical COVID-19: A Case Report.
    Doane JJ; Hirsch KS; Baldwin JO; Wurfel MM; Pipavath SN; West TE
    Am J Case Rep; 2021 Dec; 22():e933458. PubMed ID: 34848676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect and Mechanism of Qingfei Paidu Decoction in the Management of Pulmonary Fibrosis and COVID-19.
    Wu Y; Xu L; Cao G; Min L; Dong T
    Am J Chin Med; 2022; 50(1):33-51. PubMed ID: 34931591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post covid 19 pulmonary fibrosis. Is it real threat?
    Rai DK; Sharma P; Kumar R
    Indian J Tuberc; 2021 Jul; 68(3):330-333. PubMed ID: 34099197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CHARTER-Ireland trial: can nebulised heparin reduce acute lung injury in patients with SARS-CoV-2 requiring advanced respiratory support in Ireland: a study protocol and statistical analysis plan for a randomised control trial.
    Sheehan JR; Calpin P; Kernan M; Kelly C; Casey S; Murphy D; Alvarez-Iglesias A; Giacomini C; Cody C; Curley G; McGeary S; Hanley C; McNicholas B; van Haren F; Laffey JG; Cosgrave D
    Trials; 2022 Sep; 23(1):774. PubMed ID: 36104785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.